Two studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco last week found that so far relatively few people with HIV are taking doxyPEP (using the antibiotic doxycycline to prevent bacterial STIs), both in absolute terms and in the proportion of doxyPEP users who have HIV.
This seems surprising. In the US and elsewhere, people with HIV have much higher rates of STIs than similar HIV-negative people, especially gay and bisexual men and transgender women. For instance, people with HIV, mainly gay and bisexual men, account for 47% of syphilis cases in the US even though no more than 12% of gay and bisexual men have HIV.
Read the full news story at aidsmap.
View all aidsmap reports from CROI 2025
Source : aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.